February 22, 2023

Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. While the disease is relatively new, researchers are now studying its long-term effects. Some people with COVID-19 experience little to no symptoms, while others continue to experience fatigue, respiratory and neurological symptoms.

 

According to a recent report, eighty percent of individuals hospitalized for COVID-19 reported neurological symptoms. Because of this, researchers from the California National Primate Research Center at the University of California, Davis, decided to explore this complex issue further. The findings reveal significant neuron damage and inflammation in rhesus macaque monkeys within a week of infection.

 

In addition, the study unveiled an exacerbated effect in older rhesus macaques and those with Type 2 diabetes. The virus spread further in the brain, by traveling through the nose along the olfactory nerve, in aged animals and affected their memory and cognition causing particular concerns about potential spikes in neurodegenerative diseases in humans.

 

John Morrison, professor of neurology at UC Davis and director of the CNPRC, states, “In the aged monkeys, in particular, the virus is infecting neurons in regions known to be highly vulnerable to Alzheimer’s disease.” 

 

The researchers plan to continue to study the brain post-infection to examine the extent and nature of brain damage underlying the long-term neurological complications of COVID-19 to help doctors better understand how to help humans affected by the disease.

October 8, 2022

Giving birth is one of the most exciting times in parents’ lives. And doctors do everything in their power to help deliver healthy babies. This often includes providing antibiotics to protect infants from contracting an infection during vaginal or cesarean deliveries.

Currently, antibiotics directed at a wide range of bacteria are prescribed to 4-10% of all newborns.* However, new research conducted by the Cincinnati Children’s Hospital Medical Center (CCHMC) and the California National Primate Research Center (CNPRC) reveals that antibiotic treatments in newborns can change the immune system’s response to lung infections like pneumonia. 

 Researchers studied a group of rhesus macaque infants and their reactions to antibiotics vs. a group that did not receive the medication. The result? The animals that received antibiotics showed a more severe reaction to pneumonia than the control group. 

 “Early life antibiotic use has been linked to chronic health conditions in children but we don’t understand the underlying biology of these effects. This important study is the first to provide experimental evidence of a potential negative effect of antibiotic treatment in infancy in a relevant animal model of childhood development,” said Dr. Lisa Miller, co-author on the study.

The researchers will continue their studies in other animals, including mice, to eventually test and screen human babies as part of preparing to help those more at risk of contracting pneumonia after receiving antibiotics during birth.

Researchers also have a clear message for parents: infants who need antibiotics should still get them. Antibiotics transform lethal infections into minor diseases and have saved countless lives. 

“The next step is to learn how to balance the benefits of antibiotic treatment with the impact on the immune system to avoid potential health risks in susceptible infants,” says Miller.

September 19, 2022

Approximately 30,000 cases of Lyme disease are reported to CDC every year. Lyme disease transmits the Lyme disease-causing bacteria to humans through the bite of infected ticks with symptoms including fever, headaches, tiredness, and a skin rash. If Lyme is left undetected, the infection can infect the body’s joints, heart, and even nervous system. These patients can suffer from severe neurological issues, significantly diminishing their quality of life.

While antibiotics can effectively treat most cases that are detected early,, undetected infections become harder to eradicate and can cause more prolonged-term effects on people. Research about these neuroinflammation symptoms associated with Lyme disease is limited and evolving. 

 Recently, researchers at the Tulane National Primate Research Center discovered remnants of B. burgdorferi, the bacteria causing Lyme disease, may contribute to inflammation in the nervous system. In fact, these remnants can be more inflammatory (and can also cause cell death) than live bacteria, according to the trials using nonhuman primates. 

While antibiotics kill most intact bacteria in organs, some individuals cannot completely rid themselves of the remnants. Geetha Parthasarathy, Ph.D., assistant professor of microbiology and immunology at the Tulane National Primate Research Center, explains, “As neuroinflammation is the basis of many neurological disorders, lingering inflammation in the brain due to these unresolved fragments could cause long-term health consequences.”

June 22, 2022

Many previous studies explain how exposure to certain environmental substances during pregnancy may affect your baby’s health. Toxic substances increase the risk for congenital disabilities, low birth weight, prematurity, and miscarriage.

Studying the long-term effects of various environmental changes during pregnancy has occurred for decades¾from exposure to metals, cigarette smoke, stress, radiation, and more. But, recently, a new study at the California National Primate Research Center at the University of California, Davis, was published exploring the effects of wildfire smoke exposure during early pregnancy on a group of infant monkeys.

It’s typically challenging to study exposure to environmental variations during early pregnancy in women because they often aren’t aware of their pregnancies until weeks after conception. But a fire beginning on November 8, 2018, in Davis, California, provided a natural experiment in wildfire smoke exposure for a group of rhesus macaques housed close by in outdoor corrals at the California National Primate Research Center during mating season. Just under 90 monkeys were born six months later.

After months, studies proved the baby monkeys exposed to smoke had increased inflammation, reduced cortisol response to stress, memory deficits, and a more passive temperament than other animals.

Because of this study’s findings, Bill Lasley, professor emeritus of population health and reproduction at the UC Davis School of Veterinary Medicine and Center for Health and Environment, plans to study women who became pregnant through IVF. This allows him and his team to look at more prolonged-term effects of wildfire exposure with the added benefit of knowing the exact time of conception.

June 13, 2022

When you think of Rhesus macaques, one typically doesn’t feel that it has an innate ability to sense the internal state of its own body, like observing the quickening of its heartbeat. Until recently, scientists would have agreed, too. But a new study conducted by the California National Primate Research Center at the University of California, Davis, and Royal Holloway, University of London, is changing the way researchers think.

During this study, a team of researchers monitored four rhesus monkeys for their reaction to a stimulus. As it turns out, all four monkeys spent more time watching the out-of-rhythm stimuli. What does this mean? They have a human-like ability to perceive their heartbeats and have an interoceptive sense.

Interception is critically important to helping your brain identify things happening in your body, like when your breathing quickens or heart races. The brain uses information about how your body is feeling to collect feedback on your current emotions. 

Many people with conditions like ADHD, autism, trauma disorders, depression, anxiety, and Alzheimer’s disease have been found to have interception difficulties. 

Eliza Bliss-Moreau, associate professor of psychology at UC Davis and core scientist at the CNPRC states, “Our model will be used in future translational studies of neurodegenerative diseases, including Alzheimer’s. If we can measure interoception, we can track it as a behavioral biomarker of disease progression.

The published paper concludes that the next step is to study how interoception may be involved in other psychiatric and neuropsychiatric conditions.

November 18, 2021

California National Primate Research Center (NPRC) Director and neuroscientist John Morrison, PhD, is a leader in sharing science with the public. His latest public outreach effort is serving as the lead scientist behind the exhibit, “Life of a Neuron.” This comes after years of collaboration between Washington, D.C.’s technology-based art space ARTECHOUSE and the Society for Neuroscience, a professional organization that represents neuroscientists around the globe. The immersive experience marries cutting-edge science and art to illuminate the life experience of the brain’s 86 billion neurons.

Read more about the exhibit and Dr. Morrison’s involvement here, and listen to NPR’s coverage here

 

Note: The NPRCs will update this blog with our latest COVID-19 news.

Since beginning COVID-19 research in early 2020, NPRC researchers have made encouraging progress in efforts to better understand, diagnose, prevent and treat this novel disease. We’re committed to conducting and enabling research to end this global pandemic and to providing information so the public has ready access to our scientific results.

Our most recent COVID-19 news includes: 

Below is even more information about our extensive and collaborative COVID-19 research:

Diagnostics:

Prevention:

Treatments:

Additional NPRC COVID-19 News:

Bookmark this page so you can easily return here for the latest NPRC COVID-19 research information. We’ve also compiled a list of resources here and provided links to previous NPRC COVID-19 news and national media stories here.

April 27, 2021

Did you know the rhesus macaque is the most widely studied nonhuman primate in biomedical research? The U.S. research colonies of rhesus macaques were founded primarily with animals imported from India decades ago and with the addition of Chinese-origin rhesus macaques over time. A deep understanding of their evolution and genetics is key to recognizing the origins of human traits and identifying disease genes of value to improving human health.

Rhesus macaques at the seven National Primate Research Centers (NPRCs) are key in the discovery and development of new and robust models of human disease and in evaluating the effect of genetic variation on experimental treatments prior to human clinical trials.  

In a recent publication in Science that detailed researchers’ use of advanced sequencing technology and analysis of more than 850 macaques across the seven NPRCs, researchers present a complete reference genome for the rhesus macaque. “In particular, we can now finally tackle some of the more complex regions of the genome and begin to understand how new genes evolve including the processes that have shaped them,” says University of Washington genome sciences professor and senior author in the paper, Evan Eichler, PhD.

In addition, the study identified animals that naturally carry potentially damaging genetic mutations, allowing researchers to better understand genetic variation and susceptibility to diseases of relevance to humans. So far, the findings reveal thousands of naturally occurring genetic variants (mutations), including those in genes linked to Autism Spectrum Disorder and other neurodevelopmental disorders in humans, such as SHANK3.

Jeffrey Rogers, PhD, associate professor at the Human Genome Sequencing Center and Department of Molecular and Human Genetics at Baylor College of Medicine and co-author of the paper explains, “Rhesus macaques are important for studies of conditions ranging from infectious disease (including COVID-19) to neuroscience, cancer and reproductive biology. A high-quality reference genome can aid researchers who are looking to understand the causes of various illnesses or aiming to develop treatments.”

The study is a great example of a broad collaboration across the NPRCs and other research centers in the U.S. that will continue to make a difference in human health. By identifying rhesus macaques that carry naturally occurring mutations, NPRC and other researchers are now able to examine biobehavioral traits associated with mutations. The researchers can also follow the monkeys’ offspring, and, in some cases, actually create new breeding groups to generate animals with specific genetic mutations and phenotypes. 

“This new information will lay the foundation for us to create naturally occurring models of human genetic diseases,” says Paul Johnson, MD, director of the Yerkes (now Emory) NPRC. “The development of these new models could have a profound impact on our ability to translate research in animal models into treatments and cures in people,” he continues.

To learn more about NPRC advances in genetics and genomics, explore additional research here

April 20, 2021

Alzheimer’s disease (AD) affects more than 5.5 million Americans per year. This staggering prevalence makes it a high-priority disease for researchers to develop better treatments and even a cure. Researchers at California’s National Primate Research Center (CNPRC) are among those pursuing answers and believe the disease actually begins decades before the first signs of cognitive decline are triggered. 

Until recently, testing has primarily been done on transgenic mice that express a human version of amyloid or tau proteins, but these studies have proven to be difficult to translate into new medications for the human population. In contrast, nonhuman primate (NHP) models may yield new treatments by providing a closer biological link between the laboratory and clinic. 

“Humans and monkeys have two forms of the tau protein in their brains, but rodents only have one,” said Danielle Beckman, postdoctoral researcher at the CNPRC and first author on the paper. “We think the macaque is a better model, because it expresses the same versions of tau in the brain as humans do.”

Beckman and her team recommend adding an intermediate step for translational research: “If we can test therapies that work in mouse models prior to investing millions or billions of dollars into clinical trials, we really think it’s going to make an impact in having a new drug on the market. I think we really need to be open about new animal models for diseases.”

Visualization of biomarkers in the brain of NHP models may provide the key into the progression of Alzheimer’s disease. So far, teams have monitored signs of neuron death and performed positron emission tomography imaging. The effects of neurodegeneration were observed rapidly; within three months, end-stage tangles were present. And within 6 months, the progress of neurodegeneration increases markedly.

While it is still unknown whether the treated animals will present the full spectrum of Alzheimer’s Disease, including severe cognitive impairment, the initial observations have set the stage for the next steps in testing tau‐based therapeutics for AD patients. Research with monkeys is again proving critical to finding answers that can improve millions of lives worldwide. 

To learn more about the work happening at our research centers around the country, visit this link

March 3, 2021

Scientific discovery is an ongoing process that takes time, observation, data collection and analysis, patience and more. At the NPRCs, our recent COVID-19 research is an example of the ongoing basic science process — how current research builds on previous discoveries and how discoveries help improve human health. This article from the National Institutes of Health (NIH) explains why basic science, such as the NPRCs conduct, is important and how taking time, as long as it takes, is a necessary part of scientific discovery.

Discoveries in Basic Science: A Perfectly Imperfect Process

Have you ever wondered why science takes so long? Maybe you haven’t thought about it much. But waiting around to hear more about COVID-19 may have you frustrated with the process.

Science can be slow and unpredictable. Each research advance builds on past discoveries, often in unexpected ways. It can take many years to build up enough basic knowledge to apply what scientists learn to improve human health.

“You really can’t understand how a disease occurs if you don’t understand how the basic biological processes work in the first place,” says Dr. Jon Lorsch, director of NIH’s National Institute of General Medical Sciences. “And of course, if you don’t understand how the underlying processes work, you don’t have any hope of actually fixing them and curing those diseases.”

Basic research asks fundamental questions about how life works. Scientists study cells, genes, proteins, and other building blocks of life. What they find can lead to better ways to predict, prevent, diagnose, and treat disease.

How Basic Research Works

When scientists are interested in a topic, they first read previous studies to find out what’s known. This lets them figure out what questions still need to be asked.

Using what they learn, scientists design new experiments to answer important unresolved questions. They collect and analyze data, and evaluate what the findings might mean.

The type of experiment depends on the question and the field of science. A lot of what we know about basic biology so far has come from studying organisms other than people.

“If one wants to delve into the intricate details of how cells work or how the molecules inside the cells work together to make processes happen, it can be very difficult to study them in humans,” Lorsch explains. “But you can study them in a less complicated life form.”

These are called research organisms. The basic biology of these organisms can be similar to ours, and much is already known about their genetic makeup. They can include yeast, fruit flies, worms, zebrafish, and mice.

Computers can also help answer basic science questions. “You can use computers to look for patterns and to try to understand how the different data you’ve collected can fit together,” Lorsch says.

But computer models have limits. They often rely on what’s already known about a process or disease. So it’s important that the models include the most up-to-date information. Scientists usually have more confidence in predictions when different computer models come up with similar answers.

This is true for other types of studies, too. One study usually only uncovers a piece of a much larger puzzle. It takes a lot of data from many different scientists to start piecing the puzzle together.

Building Together

Science is a collective effort. Researchers often work together and communicate with each other regularly. They chat with other scientists about their work, both in their lab and beyond. They present their findings at national and international conferences. Networking with their peers lets them get feedback from other experts while doing their research.

Once they’ve collected enough evidence to support their idea, researchers go through a more formal peer-review process. They write a paper summarizing their study and try to get it published in a scientific journal. After they submit their study to a journal, editors review it and decide whether to send it to other scientists for peer review.

“Peer review keeps us all informed of each other’s work, makes sure we’re staying on the cutting-edge with our techniques, and maintains a level of integrity and honesty in science,” says Dr. Windy Boyd, a senior science editor who oversees the peer-review process at NIH’s scientific journal of environmental health research and news.

Different experts evaluate the quality of the research. They look at the methods and how the results were gathered.

“Peer reviewers can all be looking at slightly different parts of the work,” Boyd explains. “One reviewer might be an expert in one specific method, where another reviewer might be more of an expert in the type of study design, and someone else might be more focused on the disease itself.”

Peer reviewers may see problems with the experiments or think different experiments are needed. They might offer new ways to interpret the data. They can also reject the paper because of poor quality, a lack of new information, or other reasons. But if the research passes this peer review process, the study is published.

Just because a study is published doesn’t mean its interpretation of the data is “right.” Other studies may support a different hypothesis.

Scientists work to develop different explanations, or models, for the various findings. They usually favor the model that can explain the most data that’s available.

“At some point, the weight of the evidence from different research groups points strongly to an answer being the most likely,” Lorsch explains. “You should be able to use that model to make predictions that are testable, which further strengthens the likelihood that that answer is the correct one.”

An Ever-Changing Process

Science is always a work in progress. It takes many studies to figure out the “most accurate” model—which doesn’t mean the “right” model.

It’s a self-correcting process. Sometimes experiments can give different results when they’re repeated. Other times, when the results are combined with later studies, the current model no longer can explain all the data and needs to be updated.

“Science is constantly evolving; new tools are being discovered,” Boyd says. “So our understanding can also change over time as we use these different tools.”

Science looks at a question from many different angles with many different techniques. Stories you may see or read about a new study may not explain how it fits into the bigger picture.

“It can seem like, at times, studies contradict each other,” Boyd explains. “But the studies could have different designs and often ask different questions.”

The details of how studies are different aren’t always explained in stories in the media. Only over time does enough evidence accumulate to point toward an explanation of all the different findings on a topic.

“The storybook version of science is that the scientist is doing something, and there’s this eureka moment where everything is revealed,” Lorsch says. “But that’s really not how it happens. Everything is done one increment at a time.”

 

Back to top